EyePoint Pharmaceuticals, Inc. (EYPT) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
steveJohnston steveJohnston 09/18/2018 1 month $2.40 $2.99 +24.58% 24 Ended
JayJayJay JayJayJay 08/31/2017 3 months $1.21 +24.79% 0 Ended
Comments: P1 data for Knee Osteoarthritis in 4Q17 and NDA submission for Durasert. Growth potential
Pattaya Pattaya 08/19/2016 1 Year $3.93 $1.07 -72.77% -72 Ended
Comments: New tech , products, Upcoming product launch will be successful, This is a well managed company, Pro
djmounce djmounce 12/18/2014 1 Year $4.09 $3.95 -3.47% -3 Ended
Comments: the nano science of this company will be picked up by a major player soon
cards76 cards76 04/11/2013 3 months $2.35 $3.83 +63.26% 63 Ended
Comments: We feel good news is coming
simis simis 09/17/2010 3 months $4.25 $2.74 -35.53% -35 Ended
Comments: Industry sector growing or poised for growth

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.